Table 1 clinicopathological characteristics of patient samples and expressionof KDM6B in ESCC
From: KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription
characteristics | Number of cases (%) |
|---|---|
Age(y) | |
≥ 60 | 3 (7.3) |
< 60 | 38 (92.7) |
Gender | |
Male | 11 (26.8) |
Female | 30 (93.2) |
T classification | |
T1 | 1 (2.4) |
T2 | 13 (31.7) |
T3 | 23 (56.1) |
T4 | 4 (9.8) |
N classification | |
N0 | 23 (56.1) |
N1 | 13 (31.7) |
N2 | 4 (49.8) |
Lymph node Metastasis | |
No | 22 (53.7) |
Yes | 19 (46.3) |
Pathologic differentiation | |
Low | 6 (14.6) |
Medium | 18 (43.9) |
High | 17 (41.5) |
Expression of KDM6B | |
Low expression | 26 (63.4) |
High expression | 15 (36.6) |